title: New players join the drug development game.
abstract: In the hope of speeding new treatments to market, nonprofits are making targeted investments in translational research.
authors.affiliation: Rob Lott (rlott@projecthope.org) is a deputy editor at Health Affairs, in Bethesda, Maryland.
authors.forename: Rob
authors.initials: R
authors.lastname: Lott
mesh_terms: D017277:Drug Approval / Q000191:economics / Q000379:methods; D055808:Drug Discovery / Q000191:economics / Q000379:methods; D004345:Drug Industry; D006801:Humans; D009939:Organizations, Nonprofit; D012109:Research Support as Topic; D057170:Translational Research, Biomedical
keywords: Health Economics; Medical technology; Pharmaceuticals